MyFinsight
Home
About
Contact
xncr: the income statement
Download
Download image
Net loss
attributable to xencor, inc
-$6,027K
(86.98%↑ Y/Y)
Net loss including
noncontrolling interest
-$6,027K
(87.30%↑ Y/Y)
Gain (loss) on
marketable equity...
$44,201K
(377.64%↑ Y/Y)
Interest income
$6,538K
(-13.25%↓ Y/Y)
Loss before income
tax expense and...
-$6,027K
Total other income
(expense)
$41,492K
(435.04%↑ Y/Y)
Vir Biotechnology
Inc.
$1K
Incyte Corporation
$2,295K
Alexion
Pharmaceuticals Inc
$18,703K
Other, net
-$17K
(-70.00%↓ Y/Y)
Asset impairment
charges
$1,565K
Interest expense
$7,665K
(-15.08%↓ Y/Y)
Operating loss
-$47,519K
(13.91%↑ Y/Y)
Collaborations, milestones, and
royalties
$20,999K
(18.00%↑ Y/Y)
Total operating
expenses
$68,518K
(-6.13%↓ Y/Y)
General and
administrative
$14,151K
(-4.17%↓ Y/Y)
Research and development
$54,367K
(-6.63%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Xencor Inc (XNCR)
Xencor Inc (XNCR)